Model no: fgm-rs-5 Fgm optical fiber geometry analyzer is a new product after ofm optical fiber multiparameter testing system developed by rayscience .It can be used to replace the expensive imported machine. The equipment is based on grey calibrate technique of eia/tia fotp176.It is a high-precision intelligent instrument consisting of advanced optical system , ccd camera, computer and so on . Perfect software has been designed to calculate precisely all data collected from the optical fiber near field figure. The instrument can obtain the boundary of fiber cladding and diameter of core, at the same time it can provide all the geometry parameters .Test result is precise and reliable.
Integrated optics, specialty fiber, producing equipment, active components, passive components, test equipment, scientific laser, lab equipment.
Health and beauty and protective prod ppe (personnel protective equipment in stock), control & calibrator, dental merchandise, diagnostic instruments, equipment & furniture, extended care home health, gloves, infection control, instruments, iv products, lab point of care, lab equipment & accessories, medical supplies, needles & syringes, injection devices, miscellaneous products, injection products, needle removal disposal, needles, biopsy, dental safety, specialty spinal standard, syringe needle combo's, insulin safety, insulin standard, syringe needle combo safety, syringe needle combo standard, tuberculin safety, tuberculin standard, syringes, dental insulin, irrigation, miscellaneous safety specialty standard, tuberculin, orthopedic & physical therapy, patient care & exam room supplies, otc, protective apparel, radiology, respiratory & oxygen, safety and emergency, ethicons and covidiens,.
Made in Canada Health Canada approved CE Mark and ISO certified The product has proven to have 100% Specificity and 96% Sensitivety Stock availabity: 2 Million tests/kit in Canada Production: up to 5 Million tests/kit weekly The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only. PRODUCT INFORMATION: Product: Rapid Respose Sample: Nasal / Nasopharyngeal secretions Format: Cassette Quantity: 25 Tests/Kit per box Time to result: 15 minutes Storage Condition: 2-30 C/36-86 F Test Principle: Immunochromatographic Assay CONTENTS - Individually packed test devices Extraction Buffer Extraction tube Nozzle with filter Tube stand Individually packed swabs Package Insert
